Period 1 Period 2
  n Conc(ng/mL) log conc Conc(ng/mL) log conc
Hemolyzed sample 16 1322.87 ± 392.96 3.11 ± 0.12 1146.30 ± 249.89 3.05 ± 0.10
Non-hemolyzed sample 16 1151.42 ± 299.91 3.05 ± 0.11 1220.01 ± 196.67 3.07 ± 0.11
t   1.387 1.436 0.7602 0.6609
P   0.1756 0.1614 0.4531 0.5137
Ropinirole plasma concentration at 4 hour post dosing during the first period and second period Ropinirole pilot BE study
Table 2: Ropinirole Concentrations (ng/mL).